US9023817B2ActiveUtilityA1

Use of albiflorin for anti-depression

48
Assignee: ZHANG ZUOGUANGPriority: Oct 20, 2009Filed: Aug 24, 2010Granted: May 5, 2015
Est. expiryOct 20, 2029(~3.2 yrs left)· nominal 20-yr term from priority
Inventors:Zuoguang Zhang
A61K 9/4866A61P 25/24A61K 9/0019A61P 25/18A61P 25/00A61K 9/2059A61K 31/7048
48
PatentIndex Score
0
Cited by
17
References
3
Claims

Abstract

A pharmaceutical composition containing albiflorin and use thereof in manufacturing medicaments for preventing and treating depression are provided by the present invention.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
       1. A method for ameliorating and/or treating reactive depression comprising administering to a subject in need thereof a medicament consisting of Albiflorin, pharmaceutically acceptable salts, solvates or metabolites of Albiflorin, and pharmaceutically acceptable carriers. 
     
     
       2. The method of  claim 1 , wherein the medicament is in the form of tablets, capsules, pills, powders, granules, syrups, solutions, injections, sprays, aerosols or patches. 
     
     
       3. The method of  claim 1 , wherein the Albiflorin metabolites are at least one of paeonilactone A and paeonilactone B.

Join the waitlist — get patent alerts

Track US9023817B2 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.